University of South Florida
IFNγ-driven skewing towards Th1 over Th17 differentiation underlies CRS and neutropenia in CAR-T therapy
Abstract
dc:descriptionCAR-T therapy has improved overall and complete response rates, andprolonged progression free survival of patients with relapsed/refractory hematological malignancies. The short-term and long-term impacts of anti-CD19 CAR-T products on the immune landscape of B cell malignancies has garnered considerable attention in recent years. Most notably, a subset of patients experience high-grade cytokine toxicities, including cytokine release syndrome and immune cell-associated hematologic toxicity that manifest as prolonged cytopenia. Whereas etiology of CRS is more well established, the mechanisms leading to CAR-T associated cytopenia remains elusive. Rejeski et. al. showed that severe cytopenia in patients post CAR-T treatment led to frequent infections and increased hospitalizations. Onset of cytopenia was associated with worse survival owing to non-relapse mortality in patients post CAR-T treatment, thereby emphasizing the need to address these hematological toxicities. An observation drawn from two independent clinical trials was the co-occurrence of cytopenia with CRS. Among the cytopenias neutropenia was most predominant, where the decline in neutrophils intensified with the grade of CRS. We utilized an IL-2Rα knockout mouse model to recapitulate cytokine toxicities with elevated levels of IL6, IFNγ, and TNFα and increased M1-like-like macrophages. Onset of CRS was accompanied by a reduction in peripheral blood neutrophils due to a disruption of bone marrow neutrophil homeostasis characterized by an increase in apoptotic neutrophils, and adecrease in proliferative and mature neutrophils. Both non-tumor-bearing and Eμ- ALL tumor-bearing mice recapitulated the co-occurrence of CRS and neutropenia. IFNγ-blockade alleviated both CRS and neutropenia without affecting CAR-T efficacy. Mechanistically, a Th1-Th17 imbalance was observed to drive cooccurrence of CRS and neutropenia in an IFNγ-dependent manner, leading to decreased IL-17A and G-CSF, neutrophil production, and neutrophil survival. In patients, we observed an increase in the IFNγ-to-IL-17A ratio in the peripheral blood during high-grade CRS and neutropenia. We have uncovered a biological basis for ICAHT and provide support for the use of IFNγ-blockade to reduce CRS and neutropenia.
Degree
thesis:*- Name thesis:degree_name
- Doctor of Philosophy (Ph.D.)
- Level thesis:degree_level
- Dissertation
- Discipline thesis:degree_discipline
- Biology (Cell Biology, Microbiology, Molecular Biology)
- Grantor
- University of South Florida
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Goala, Payal
- Contributors dc:contributor
-
- Marco L. Davila,MD, Ph.D.
- Michael D. Jain,MD, Ph.D.
- Paulo Rodriguez, Ph.D.
- Jose Alejandro Guevara,MD, Ph.D.
Subjects
dc:subject × 10Identifiers
dc:identifier.*- Repository record dc:identifier
- https://digitalcommons.usf.edu/etd/11293